ArticleERJ open research2020

CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin.

Holly R Keir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.